StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Pre-Open Stock Movers 10/05: (ONCE) (FOLD) (TWTR) Higher; (APP) (FEYE) (VRX) Lower (more...)
October 5, 2015 9:24 AM
Spark Therapeutics (NASDAQ: ONCE) 37.4% HIGHER; announced positive top-line results from the Phase 3 pivotal trial of its lead gene ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Special Reports
Next Articles
Brean Capital Reiterates Buy on Twitter (TWTR) Following 'Moments' Launch
October 7, 2015 11:55 AM
Piper Jaffray Remains Bullish on Lam Research (LRCX) as Technology Inflections Continue
October 6, 2015 7:19 AM
Roth Capital Raises Price Target on Spark Therapeutics (ONCE) to $90 Following Top-Line Results
October 5, 2015 11:03 AM
Cowen Remains Bullish on Spark Therapeutics (ONCE) Following Top-Line SPK-RPE65 Results
October 5, 2015 10:14 AM